claim: 8/11 on omalizumab + milk oit reached 1000mg in schneider's 2013 study.
article_headline: full article: oral immunotherapy for the treatment of food allergy
initial_claim: experimental treatment helps 2 out of 3 peanut allergy sufferers, study finds